FC
Insider
Fred E Cohen
DirectorFred E Cohen (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Intellia Therapeutics, Inc. (NTLA). Across 1 priced purchase filing, the average 21-session return was +41.7% from execution and +12.7% from disclosure (delay-adjusted; derived). The largest single filing was $1.4M of NTLA (150,000 sh × $9.35, as filed), executed Jan 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+41.7%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+12.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Jan 5
Filed Jan 7
Median ADV $62.4M across their filed names
Open performance→Volume by month
Buys $1.4M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
NTLARecent filings
NTLAPURCHASE
Intellia Therapeutics, Inc.
View filing →
$1.4M150,000 sh × $9.35
Exec Jan 5
Filed Jan 7 · 4:05 PM ET